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1  | INTRODUC TION
Targeted early intervention into controllable factors such as parenting 
quality, access to quality education, health care, and adequate nutrition 
in the first years of life is associated with lifelong beneficial outcomes 
(e.g., Muennig et al., 2009; Campbell et al., 2012). These benefits, which 
outweigh the costs of initial intervention, can be seen at individual (e.g., 
greater social competence, more earnings, higher educational attain‐
ment) and societal levels (e.g., decreased rates of delinquency/crime; 
higher tax revenues; Karoly, Kilburn, & Cannon, 2005). Moreover, early 
investment is often cost‐effective and associated with larger benefits 
than later remediation (Carneiro & Heckman, 2003). Given this, fund‐
ing and promoting research aimed at identifying potential targets for 
early intervention, particularly in communities at risk for unfavorable 
outcomes, should be a top priority for lawmakers and funders.
One burgeoning line of work that may have a place in early inter‐
vention is that concerning the microbiota–gut–brain axis. In this man‐
uscript, we begin by briefly examining the role of the gut microbiota 
in human life, focusing on links with health, cognition, and behavior. 
Following this, we discuss the development of the gut microbiota and 
the critical early window in which colonization occurs. Then, we re‐
view current nonnutritive means of influencing the gut microbiota in 
early life. Finally, we discuss the implications this work has for early 
intervention in low‐income communities and end with recommen‐
dations regarding further research and research funding priorities.
2  | THE MICROBIOTA–GUT–BR AIN A XIS
The human gut contains more than 10 trillion microbes, comprised 
largely of bacteria but also including archaea, fungi, yeasts, and pro‐
tozoa. These microscopic microbes, collectively known as the gut 
microbiota, are so numerous that they weigh approximately the 
same as a human brain (Dinan et al., 2015). The gut microbiota oper‐
ates as a metabolic organ, taking on functions not encoded in the 
human genome such as generating metabolites not produced by the 
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Abstract
Fostering healthy developmental growth in the first years of life is associated with 
numerous favorable cognitive, social, and economic outcomes. Funding and promot‐
ing research aimed at identifying potential targets for early intervention should be a 
top priority for lawmakers and funders. One promising avenue of research and po‐
tential early intervention is the microbiota–gut–brain axis. In this report, we briefly 
examine the role of the gut microbiota in human life, focusing on links with health, 
cognition, and behavior. We then discuss the development of the gut microbiota and 
the critical early window in which colonization occurs. Then, we review current non‐
nutritive means of influencing the gut microbiota in early life. Finally, we discuss the 
implications this work has for early intervention in low‐income communities and end 
with recommendations regarding further research and research funding priorities.
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human body (Gonzalez et al., 2011) and providing essential nutrients 
from some polysaccharides and carbohydrates that are otherwise 
indigestible (Adlerberth & Wold, 2009; Diaz Heijtz, 2016). Further, 
the gut microbiota is implicated in the development, maturation, and 
maintenance of many essential systems in human health, such as 
the immune system (de Weerth, 2017), gastrointestinal tract (Diaz 
Heijtz, 2016), and metabolism (Nicholson et al., 2012; Tremaroli & 
Bäckhed, 2012).
Current research also indicates a role for the gut microbiota in 
the development of the brain and finds evidence for bidirectional 
communication between the two (e.g., Fung, Olson, & Hsiao, 2017). 
The enteric nervous system, a system of neurons embedded in the 
lining of the gastrointestinal system, relies on neural, endocrine, im‐
mune, and humoral pathways to enable gut–brain communication 
(Carabotti, Scirocco, Maselli, & Severi, 2015). Moreover, intestinal 
bacteria can produce neurotransmitters such as serotonin that have 
the potential to affect the brain, human behavior, emotions, and po‐
tentially even higher order cognition such as decision‐making and 
planning (Cryan & Dinan, 2012; Strandwitz, 2018). The close com‐
munication between the gut and the brain, as well as the microbi‐
ota–gut–brain axis’ role in fostering the development of vital human 
systems, illustrates the key role this axis plays in development and 
health.
2.1 | The microbiota and health
Research is rapidly uncovering links between the gut microbiota and 
human health and disease. Much of the knowledge underlying this 
research comes from experimental animal models capable of dem‐
onstrating causal links between microbial manipulations and specific 
physiological or behavioral outcomes. For example, some studies use 
germ‐free rodents raised in sterile environments to determine how 
living without a microbiota affects development. Others use anti‐
biotics to induce intestinal microbial imbalances in typically devel‐
oping animals, or probiotics, defined as “live microorganisms which, 
when administered in adequate amounts, confer a health benefit on 
the host” (Food & Agriculture Organization of the United Nations/
World Health Organization, 2002), to examine the effects of pro‐
moting gut health. In humans, experimental methods to examine the 
links between the gut microbiota and health are generally limited to 
randomized controlled trials involving probiotics or treatments for 
ill individuals. More commonly, scientists use cross‐sectional stud‐
ies in which the microbiota of two or more groups of interest are 
compared.
A healthy gut microbiota is one that evinces diverse colonization 
in which microorganisms with positive effects on health are more 
numerous than ones that may be harmful and in which the enteric 
cells of the intestinal wall effectively contain these bacteria, pre‐
venting them from entering the bloodstream. Contrarily, dysbiosis 
refers to a microbial imbalance in which harmful bacteria dispro‐
portionately colonize the gut in response to host‐mediated inflam‐
mation. This inflammation typically results from infection, a genetic 
predisposition, or a chemical trigger of some sort (e.g., Lupp et al., 
2007; Rawls, 2007). Studies in animals and adult humans suggest 
that a healthy gut microbiota is implicated in many physiological, 
metabolic, and immune‐related processes (for reviews see, Haase et 
al., 2018; Pascale et al., 2018; Rowland et al., 2017), whereas dysbi‐
osis is associated with metabolic, inflammation‐related, pancreatic, 
and intestinal diseases such as obesity, cancer, and cardiovascular 
disease (for reviews see, Akshintala, Talukdar, Singh, & Goggins, 
2018; Castaner et al., 2018; Feng, Chen, & Wang, 2018; Lazar et al., 
2018; Pascale et al., 2018; Wang & Zhao, 2018).
The microbial influence on health begins early in life. For example, 
early gut microbiota alterations in mice (induced by an antibiotic) can 
have long‐term consequences on adult metabolic functioning and 
adiposity (Cox et al., 2014). In humans, associations between early 
microbiota composition and child health are well documented and 
growing. Studies examining the correlates of antibiotic use, probiotic 
use, and microbiota composition suggest that imbalances in the gut 
microbiota in infancy and childhood are implicated in: increased risk 
for child obesity (e.g., Dogra et al., 2015; Kozyrskyj, Kalu, Koleva, 
& Bridgman, 2016), irritable bowel syndrome (e.g., Saulnier et al., 
2011), allergies (e.g., Noverr & Huffnagle, 2005), atopic disorders 
(Penders et al., 2007), and asthma (e.g., Kummeling et al., 2007). 
Research continues to emerge illustrating the gut microbiota's im‐
portance in establishing and maintaining physical health beginning 
in the earliest days of life.
2.2 | The microbiota, cognition, and behavior
The microbiota–gut–brain axis is likely also involved in a wide va‐
riety of cognitive processes in living creatures. In animal studies, 
the gut microbiota is implicated in learning, stress, addiction, and 
some social behaviors (for reviews see Cussotto et al., 2018; Münger, 
Montiel‐Castro, Langhans, & Pacheco‐López, 2018). Studies with 
adult humans demonstrate a tentative link between the gut micro‐
biota and mood disorders (see Liu & Zhu, 2018), but the findings 
regarding this and other forms of cognition are less consistent, par‐
ticularly in studies using probiotics (see Sarkar et al., 2018). The gut 
microbiota may also be implicated in some neuroimmune diseases, 
including Parkinson's and Alzheimer's diseases, schizophrenia, mul‐
tiple sclerosis, and autism spectrum disorders (see Lombardi et al., 
2018).
It is surprising that few studies have yet examined relations be‐
tween microbiota composition and cognition in infants and young 
children, as this is when potential effects may be largest (de Weerth, 
2017). In the few studies examining the association between pro‐
biotics or prebiotics (defined as “a substrate that is selectively uti‐
lized by host microorganisms conferring a health benefit”; Gibson et 
al., 2017) and cognition in healthy infants and children, the findings 
are mixed. Some studies find no difference in neurodevelopmental 
outcomes between infants who have and have not ingested pro‐
biotics, despite the presence of physical health benefits (e.g., Akar 
et al., 2016; Sari et al., 2012), whereas others have found improved 
social and school functioning in young children who ingest them 
(e.g., Ringel‐Kulka, Kotch, Jensen, Savage, & Weber, 2015). Studies 
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examining gut microbial composition and behavior have found that 
early microbial composition is linked with colic in very young infants 
(de Weerth, Fuentes, & de Vos, 2013; de Weerth, Fuentes, Puylaert, 
& de Vos, 2013; Rhoads et al., 2018) and aspects of temperament, 
visual reception, and language acquisition in toddlers (Carlson et al., 
2018; Christian et al., 2015).
2.3 | Mechanisms underlying gut–brain associations
The mechanisms accounting for the gut microbiota's links with phys‐
ical and mental health have yet to be fully elucidated but are likely 
complex and overlapping. For instance, researchers have proposed 
that some of the metabolites produced by the microbiota (e.g., short‐
chain fatty acids; Chambers, Preston, Frost, & Morrison, 2018), serve 
a communicatory role within the central nervous system. They can 
induce important physiological changes capable of affecting immune 
functioning and health. Studies with animals also demonstrate that 
microbial alterations can induce several neurochemical changes (e.g., 
altered brain‐derived neurotrophic factor levels in the hippocampus 
and cortex; reduced synaptic plasticity gene expression; Diaz Heijtz 
et al., 2011; Neufeld et al., 2010; Sudo et al., 2004) capable of affect‐
ing the brain and behavior. For detailed reviews of these and other 
mechanisms, see Bruce‐Keller, Salbaum, and Berthoud (2018) and 
Martin, Osadchiy, Kalani, and Mayer (2018). This preliminary work 
suggests that the microbiota–gut–brain axis plays a complex part in 
human functioning and that a healthy microbiota may be an essential 
component of optimal development.
2.4 | The development of the gut microbiota
The development of the human microbiota likely begins prenatally. 
The intrauterine environment hosts both gram‐positive and gram‐
negative bacteria in a moderate percentage of mothers at time of 
delivery (Stout et al., 2013), and microbes have been identified in the 
placenta (Aagaard et al., 2014). Infants are nonetheless born with 
nearly sterile intestines with a very low and nondiverse bacterial 
load in the meconium (de Weerth, Fuentes, Puylaert, et al., 2013). 
Intestinal population by bacteria largely occurs during delivery or 
shortly thereafter as the infant gut is colonized with dozens of bac‐
terial species in the first days of life.
Over the next few years, the diversity of these bacterial spe‐
cies and their associated functions increase rapidly, slowing in early 
childhood (see Lynch & Pedersen, 2016, for a review; Cheng et al., 
2016; Yatsunenko et al., 2012) but continuing into adulthood. The 
number of bacterial taxonomic groups and functional genes in the 
microbiota is like those of adults by preadolescence, but even then, 
the functionality of the microbiome differs and is more focused on 
developmental processes (such as vitamin synthesis) than processes 
of aging (such as controlling inflammation and obesity; Hollister et 
al., 2015). Among healthy children and adults, evidence indicates 
only 35%–45% taxonomic similarity in microbiota composition but 
90%–96% similarity in functionality, indicating that microbiota‐re‐
lated health lies not only in the composition of the microbiota, but 
also in its diversity and functions in development (Hollister et al., 
2015; Human Microbiome Project Consortium, 2012).
Considering that the human brain is also developing in the first 
years of life, it is reasonable to hypothesize that gut microbial influ‐
ences on the brain may be largest in early development (de Weerth, 
2017). Animal models provide support for this notion, finding that 
the early gut microbiota plays a pivotal role in synaptogenesis 
and the myelination of brain areas associated with motor control 
and cognitive functioning (Diaz Heijtz, 2016; Hoban et al., 2016). 
Moreover, the gut microbiota is associated with microglia matura‐
tion and function, both of which are critical in the development of 
the immune system (Erny et al., 2015). Research in humans pro‐
vides preliminary support as well, finding that late bacterial acqui‐
sition and low bacterial diversity in the microbiota are associated 
with delayed maturation of the immune system in the first 2 years 
of life (Jakobsson et al., 2014). In addition, many of the metabolic 
functions (e.g., metabolism of nutrients and energy transfer from 
the diet; Diaz Heijtz, 2016) of the intestinal microbiota are impli‐
cated in healthy brain development processes that occur during 
early sensitive or critical periods.
For this reason, fostering early, diverse, and balanced microbial 
colonization of the gut is vital for establishing the bacterial commu‐
nity needed to set children on a healthy developmental trajectory 
early in life. Research indicates that breastfeeding may play a critical 
role in this, providing the infant gut with both bacteria and human 
milk oligosaccharides (HMOs; Martín et al., 2012). HMOs are a di‐
verse set of glycans that, although indigestible to humans, promote 
the growth of healthy strains of bacteria in the infant gut (Bode, 
2012). Exclusive breastfeeding in the first 6 months of life protects 
the microbiota, increasing its resistance to external influences in in‐
fancy (Carvalho‐Ramos, Duarte, Brandt, Martinez, & Taddei, 2018). 
Other research on microbial manipulation focuses on the promise 
of dietary intervention using probiotics and prebiotics, presented 
elsewhere in this special issue. However, a multitude of factors be‐
yond diet are implicated in early colonization, including the health 
of the maternal microbiota, type of delivery, environmental sanitary 
conditions, antibiotic use, and even the presence of siblings or pets 
(Adlerberth & Wold, 2009; Koenig et al., 2011; Song et al., 2013). In 
the following section, we discuss nonnutritive means to potentially 
influence the gut microbiota in infancy.
3  | INFLUENCING THE GUT MICROBIOTA 
IN E ARLY DE VELOPMENT
3.1 | Managing the maternal microbiota
Evidence suggests that the human body prepares itself for deliv‐
ery by altering the prevalence of certain bacterial phylotypes in the 
maternal microbiota of various body sites (e.g., the gut, vagina, oral 
cavity, placenta; Nuriel‐Ohayon, Neuman, & Koren, 2016). However, 
environmental influences can still affect the composition and di‐
versity of the maternal microbiota, and this can have consequences 
on the pregnancy and child outcomes (Dunlop et al., 2015). Two 
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particularly important influences on the maternal microbiota and 
potentially the infant microbiota during pregnancy are maternal use 
of antibiotics and maternal stress.
3.1.1 | Antibiotics
Unnecessary antibiotics during pregnancy may be a barrier to op‐
timal infant gut colonization. Several studies note an association 
between prenatal antibiotic use and reduced abundance of healthy 
bacteria in offspring at birth (e.g., Mshvildadze et al., 2010; Keski‐
Nisula et al., 2013). One study cites an 84% increased risk of de‐
veloping childhood obesity in children whose mothers received any 
type of antibiotic prenatally (Mueller et al., 2015). Currently, many 
pregnant women are prescribed antibiotics known to cross the pla‐
centa (Langdon et al., 2016). These antibiotics can be lifesaving and 
medically necessary. However, until their full effects on the infant 
microbiota can be explored, judicious and limited antibiotic use is 
warranted during pregnancy and labor.
3.1.2 | Stress
In addition, regulating maternal stress during pregnancy may prove 
to be an important step in promoting healthy colonization of the 
unborn child's gut microbiota (de Weerth, 2017, 2018). Evidence 
indicates that both self‐reported and physiologically measured 
prenatal maternal stress may influence the infant microbiota. One 
study found that infants of stressed mothers had a microbiota 
profile characteristic of increased inflammation, and more mother‐
reported infant gastrointestinal problems and allergic reactions 
(Zijlmans, Korpela, Riksen‐Walraven, de Vos, & de Weerth, 2015). 
Although preliminary, this and other animal studies (e.g., Bailey, 
Lubach, & Coe, 2004) demonstrate that maternal prenatal stress 
may have a lasting and negative effect on the infant microbiota. 
While it is not always possible to manage maternal stress, programs 
aimed at its reduction (e.g., stress‐reducing interventions and par‐
enting programs; paid maternal leave and access to health care) 
may be an important step in promoting healthy infant microbiota 
development. In addition, prenatal screening for maternal stress 
may help identify mothers who need additional support during 
pregnancy.
3.2 | Cesarean delivery (C‐section)
Mode of delivery has a direct impact on microbial composition and 
diversity (e.g., Biasucci et al, 2010; Dominguez‐Bello et al., 2010). 
Studies show that children born via vaginal delivery have gut micro‐
biota resembling the fecal and vaginal flora of their mother, whereas 
children born via C‐section have gut microbiota resembling the 
mother's skin or oral flora or the birth environment (e.g., Bäckhed 
et al., 2015). In addition, C‐sections potentially delay crucial mother 
infant skin‐to‐skin contact and the initiation of breastfeeding (Prior 
et al., 2012), two important contributors to early microbial devel‐
opment. Many C‐sections also include giving the mother powerful 
antibiotics (either before or during the operation; Smaill & Grivell, 
2014) to avoid postoperative infection. Antibiotics administered be‐
fore the umbilical cord is clamped are potentially transferred to the 
fetus; their effect on the newly developing microbiota is unknown 
(Smaill & Grivell, 2014). The combined effect of these factors pre‐
sents a substantial risk for the healthy colonization and development 
of the infant microbiota. In fact, differences in gut microbial colo‐
nization and microbiota diversity that are associated with mode of 
delivery have been reported at 6 months (Rutayisire, Huang, Liu, & 
Tao, 2016), 2 years (Jakobsson et al., 2014), and even in adulthood 
(Goedert, Hua, Yu, & Shi, 2014), although another study found no 
differences (Chu et al., 2017).
Early microbial differences may have long‐term impacts on in‐
dividual health. C‐section is linked with a host of later developing 
diseases, many of which are also associated with a disrupted micro‐
biota. For example, one retrospective study in more than 2 million 
Danish children found increased rates of asthma, juvenile arthritis, 
systematic connective tissue disorders, inflammatory bowel disease, 
immune deficiencies, and leukemia among children born via C‐sec‐
tion (Sevelsted, Stokholm, Bønnelykke, & Bisgaard, 2015). Other 
studies confirm that C‐section is associated with increased risk for 
diseases linked with microbial alterations, such as obesity (e.g., Li, 
Zhou, & Liu, 2013), gastroenteritis, asthma, and autoimmune disease 
later in life (e.g., Kristensen & Henriksen, 2016). Importantly, these 
outcomes may also be associated with the medical indications for 
having a C‐section (e.g., abnormal labor). However, given the link of 
these diseases with microbial alterations, investigating the role of 
the microbiota in their development is warranted too.
The World Health Organization currently recommends C‐section 
only be performed in cases where it is medically necessary (Betran, 
Torloni, Zhang, & Gülmezoglu, 2015). Medical providers can increase 
chances of vaginal birth by following evidence‐based guidelines that 
take into account typical labor progression and fetal heart moni‐
toring during birth (Spong, Berghella, Wenstrom, Mercer, & Saade, 
2012). In addition, studies should continue to examine care options 
that increase chances of acquiring a healthy gut microbiota in infants 
born via C‐section (e.g., Smith, Plaat, & Fisk, 2008).
3.3 | Vaginal seeding
Vaginal seeding, a controversial procedure that may offer a way to 
influence the microbiota of infants born by C‐section, is the pro‐
cess of inoculating a sterile cotton gauze or swab with the mother's 
vaginal fluids prior to delivery and transferring her vaginal bacteria 
to her neonate by swabbing his or her mouth, nose, and skin with 
it. The only study to date on vaginal seeding found that four ce‐
sarean‐born infants who underwent vaginal seeding had oral, skin, 
and anal microbiota that more closely resembled those of vaginally 
born infants than cesarean‐born infants for one month postbirth 
(Dominguez‐Bello, et al., 2016). Despite a lack of research, vaginal 
seeding has gained traction in the scientific community and media. 
This has led some authors to call for caution due to the very real 
risk of spreading unknown maternal infections to vulnerable infants, 
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particularly since the link between C‐section and later illness is likely 
the result of multiple factors and not simply lack of contact with 
the maternal microbiota (e.g., Cunnington et al., 2016; Stinson, 
Payne, & Keelan, 2018). The American College of Obstetricians and 
Gynecologists currently recommends that vaginal seeding only be 
performed in the context of institutional review board‐approved re‐
search (ACOG, 2017).
3.4 | Delivery and postbirth practices
Doctors and nurses involved in pre‐ and postnatal care have the po‐
tential to influence the colonization of the infant microbiota through 
the care decisions they make. Although controversial, there is some 
evidence that certain common procedures, such as frequent cervi‐
cal exams, urinary catheterization, and electronic fetal monitoring, 
while not associated with the microbiota directly, can increase risk 
for infections that result in antibiotic use or cesarean birth (Jansen, 
Gibson, Bowles, & Leach, 2013). Care providers present at the time 
of birth can encourage mothers to make early skin‐to‐skin contact if 
appropriate and to initiate breastfeeding if the mother plans to do 
so. Finally, the use of preventive antibiotic treatment in the neonate 
may affect normal microbial colonization (see Neuman, Forsythe, 
Uzan, Avni, & Koren, 2018 for a review). Although more prospec‐
tive multicentered research is warranted before modifying care pro‐
tocols, a recent study found that the use of antibiotics in neonates 
with suspected early‐onset sepsis can be reduced by 44% through a 
change in medical practices (Achten, Dorigo‐Zetsma, van der Linden, 
van Brakel, & Plötz, 2018).
3.5 | Fecal transplant
Although fecal transplant is currently only employed to treat life‐
threatening recurrent Clostridium difficile infection in adult popula‐
tions, mentioning it here is warranted as it may one day prove to 
be a valuable technique for positively manipulating the gut micro‐
biota in early life as well. Fecal microbial transplantation involves 
transferring the stool (or its cryopreserved microbial components) 
of a healthy donor to an individual with a dysbiotic or pathogenic 
gut microbiota. This is traditionally accomplished via a nasogas‐
tric or nasoenteric tube, an enema, or is done during an endos‐
copy. Recently, researchers have also developed acid resistant oral 
capsules containing the donor's cryopreserved microbes (Patel & 
Spector, 2016; Youngster et al., 2014; and see Bouri & Hart, 2018, 
for a review of current best practices). Studies have also begun to 
examine whether fecal transplant can be used to treat irritable 
bowel syndrome, ulcerative colitis, Crohn's disease, and the gastro‐
intestinal and social symptoms in autism (Holleran et al., 2018; Kang 
et al., 2017). Evidence suggests that the risks associated with fecal 
transplant are low (Baxter & Colville, 2016; Meyers, Shih, Neher, & 
Safranek, 2018), even in immunocompromised and elderly popula‐
tions (Agrawal et al., 2016; Kelly et al., 2014). However, more re‐
search is needed to ascertain the full scope of risks associated with 
the procedure.
4  | IMPLIC ATIONS FOR LOW‐INCOME 
COMMUNITIES
The literature just reviewed holds promise for all human popu‐
lations, but for some, may represent a critical step in improving 
health outcomes. One vulnerable population that may benefit 
from continued research into the microbiota–gut–brain axis is the 
socioeconomically disadvantaged. Low socioeconomic status (SES) 
is associated with multiple risk factors linked with later mental and 
physical illness, such as early life stress, adverse childhood experi‐
ences (e.g., Cambois & Jusot, 2011; Chapman et al., 2004; Dong et 
al., 2004), reduced access to healthcare (Anderson & Armstead, 
1995), increased engagement in unhealthy behaviors like smok‐
ing and alcohol dependency (Bloomfield et al., 2006; Marmot, 
2006), and decreased engagement in positive health behaviors like 
healthy eating and exercise (Brug, 2008; Gidlow, Johnston, Crone, 
Ellis, & James, 2006). Low‐SES status across the globe is associ‐
ated with higher rates of morbidity and mortality (e.g., Signorello 
et al., 2014) and higher incidence of some of the diseases previ‐
ously mentioned in this review, such as asthma (Shankardass et al., 
2011) and diabetes (Krishnan, Cozier, Rosenberg, & Palmer, 2010). 
Moreover, low SES is also associated with lower cognitive abilities 
in middle childhood (Lawlor et al., 2006) and adulthood (Kobrosly 
et al., 2011).
It is unclear whether these disparities in mental and physical 
health are at least in part a direct (or indirect) result of differences 
in gut microbiota composition, but there are reasons to hypothe‐
size that they may be (Rook, Raison, & Lowry, 2014). Many char‐
acteristics associated with low‐SES neighborhoods and lifestyles 
(e.g., processed foods, sedentary lifestyle, psychosocial stress, ex‐
posure to pollutants and endocrine disrupters) are also associated 
with reduced gut microbial diversity (Conlon & Bird, 2014; Diez 
Roux & Mair, 2010). Studies also show that low‐income women are 
less likely to breastfeed than women from high‐SES backgrounds 
(in high‐income countries; e.g., Heck, Braveman, Cubbin, Chávez, 
& Kiely, 2006; Ruijsbroek et al., 2011), even when they express 
the intention to do so in pregnancy (Conner et al., 2013). Only two 
studies so far have examined differences in microbial composition 
between high‐ and low‐SES populations. In one, higher SES was 
associated with greater alpha‐diversity and population rates of 
particular microbes in the colonic microbiota (Miller et al., 2016). 
In the other, distinct differences in microbial composition were 
found between the gut microbiota of low‐income Bangladeshi 
children and upper‐ to middle‐class American children of the same 
age (Lin et al., 2013). In both cases, the effects of these differences 
on health are unknown. However, given the importance of the gut 
microbiota in health and its role in brain development, low‐cost 
interventions aimed at positively altering microbial composition 
in early life may be especially promising for disadvantaged com‐
munities. Importantly, although SES is a common measure of dis‐
advantage, these benefits could also be promising for higher SES 
communities in other disadvantaged (e.g., war‐torn; high stress) 
contexts.
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5  | FUTURE DIREC TIONS AND 
RECOMMENDATIONS IN MICROBIOTA 
RESE ARCH
Although the body of literature just reviewed speaks to the promise 
this line of work holds for influencing healthy development early in 
life, substantial gaps in knowledge still exist. Supporting research 
into the microbiota–gut–brain axis should be a top concern for fund‐
ing agencies and policy makers interested in identifying potential 
targets for affordable early intervention. Funding should be pri‐
oritized toward three types of research that are likely to generate 
new knowledge that can be applied to programs promoting physical 
and mental health in humans: basic, intervention, and longitudinal 
research.
5.1 | Basic research and the promise of omics 
technologies
It is largely thanks to the recent metagenomic revolution that we can 
explore and characterize the composition of the gut microbiome (i.e., 
the complete set of genes associated with the microbiota), its basic 
functions, and its links with health and disease. Researchers should 
continue to expand on this burgeoning knowledge with cross‐dis‐
ciplinary investigations to build a complete picture of the complex 
functionality of the microbiota. Researchers in the fields of genom‐
ics (e.g., Feero & Guttmacher, 2014), metabolomics (e.g., Patti et al., 
2012), culturomics (e.g., Lagier et al., 2018), proteomics (e.g., Ruiz et 
al., 2016), and transcriptomics (e.g., Castro‐Nallar et al., 2015) should 
employ a multiomic approach to cataloguing the incredible variety of 
microbes in the human microbiota, their metabolic functions, their 
relative activity in the gut, and their communication and interactions 
with each other and the brain. Such cross‐collaboration will allow 
scientists to zero in on microbial profiles associated with favorable 
and maladaptive outcomes. As mentioned, even healthy adults do 
not have one specific gut microbial composition, so understand‐
ing the wide variety of profiles or specific microbes that can confer 
health benefits or risks will be an important step in identifying and 
treating at‐risk or disordered gut microbial communities.
5.2 | Intervention research
In addition, funding should be allocated for researchers interested in 
creating and studying affordable interventions designed to influence 
gut health. When possible, RCTs will move the field from correla‐
tional to causational research. Top priority should be given to studies 
that attempt to combine basic science and intervention research, as 
these are the studies that will begin to identify the mechanisms be‐
hind structural and functional changes in the microbiome and their 
influences on health, behavior, and cognition.
Interventions using probiotics are certainly relevant to this en‐
deavor, as probiotics are an increasingly affordable (e.g., Reid et al., 
2018) and low‐risk (e.g., van den Nieuwboer et al., 2015; van den 
Nieuwboer, Claassen, Morelli, Guarner, & Brummer, 2014) means 
of influencing gut health (e.g., George Kerry et al., 2018). Similarly, 
interventions using prebiotics will yield valuable insights into bac‐
terial proliferation and microbial maintenance. Other potentially 
low‐cost interventions aimed at improving gut health might include 
components designed to: increase exclusive breastfeeding in the 
first months of life, reduce maternal prenatal stress, and increase 
the chance of vaginal delivery. In addition, interventions designed 
to affect other facets of health may benefit from including the gut 
microbiota as an additional variable of interest. It may be that other 
lifestyle factors (e.g., psychosocial support, participation in psycho‐
therapy, the use of alcohol or other recreational drugs) have undis‐
covered influences on gut health.
5.3 | Longitudinal work
Finally, research examining the development of the microbiota 
longitudinally can help elucidate when and how profiles shift and 
what additional factors beyond those discussed here might in‐
fluence their evolution. Such investigations may clarify whether 
sensitive or critical periods exist for developing, maintaining, and 
treating gut health in humans. Of particular interest to funders 
might be investigations intending to combine all three types of re‐
search mentioned here. Longitudinal investigations meant to track 
gut microbial changes in response to intervention, and how those 
changes influence health, cognition, and behavior, represent a 
critical step in uncovering ways in which the microbiota–gut–brain 
axis can be used as a tool to set humans on a healthy developmen‐
tal trajectory early in life.
6  | SUMMARY
The preceding sections present a substantial body of literature 
describing the gut microbiota's potential role in human health, 
cognition, and behavior. Following this, and the potential role of 
the gut microbiota in brain development, we presented the case 
that the earliest days of life may represent a particularly critical 
time for intervening in gut health to ensure healthy developmental 
outcomes. Attempts to positively influence the gut microbiota are 
in their infancy as we discover new targets of intervention and 
methods of manipulation. Continued investigations into the basic 
science behind the microbiota–gut–brain axis and the potential 
benefits of its role in early intervention may prove to be a key step 
in achieving the United Nation's Sustainable Development Goal 
for people to “ensure that all human beings can fulfill their poten‐
tial in dignity and equality (UN General Assembly, 2015).” Such a 
goal benefits not only the recipients of such intervention, but the 
societies they live in as well.
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